ATE342064T1 - Verwendung von humanem wachstumshormon zur vermehrung der anzahl zirkulierender cd34+ zellen,zur wiederherstellung des hämapoietischen- und des immunsystems nach myeloablativer oder antiblastischer therapie, bei transplantation oder re-infusion - Google Patents

Verwendung von humanem wachstumshormon zur vermehrung der anzahl zirkulierender cd34+ zellen,zur wiederherstellung des hämapoietischen- und des immunsystems nach myeloablativer oder antiblastischer therapie, bei transplantation oder re-infusion

Info

Publication number
ATE342064T1
ATE342064T1 AT99965579T AT99965579T ATE342064T1 AT E342064 T1 ATE342064 T1 AT E342064T1 AT 99965579 T AT99965579 T AT 99965579T AT 99965579 T AT99965579 T AT 99965579T AT E342064 T1 ATE342064 T1 AT E342064T1
Authority
AT
Austria
Prior art keywords
cells
growth hormone
antiblastic
hemapoietic
myeloablative
Prior art date
Application number
AT99965579T
Other languages
German (de)
English (en)
Inventor
Alessandro Massimo Gianni
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE342064T1 publication Critical patent/ATE342064T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99965579T 1998-12-30 1999-12-30 Verwendung von humanem wachstumshormon zur vermehrung der anzahl zirkulierender cd34+ zellen,zur wiederherstellung des hämapoietischen- und des immunsystems nach myeloablativer oder antiblastischer therapie, bei transplantation oder re-infusion ATE342064T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (en) 1998-12-30 1998-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (1)

Publication Number Publication Date
ATE342064T1 true ATE342064T1 (de) 2006-11-15

Family

ID=8233268

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99965579T ATE342064T1 (de) 1998-12-30 1999-12-30 Verwendung von humanem wachstumshormon zur vermehrung der anzahl zirkulierender cd34+ zellen,zur wiederherstellung des hämapoietischen- und des immunsystems nach myeloablativer oder antiblastischer therapie, bei transplantation oder re-infusion

Country Status (15)

Country Link
US (1) US20060029581A1 (cg-RX-API-DMAC7.html)
EP (3) EP1016413A1 (cg-RX-API-DMAC7.html)
JP (1) JP4808316B2 (cg-RX-API-DMAC7.html)
AT (1) ATE342064T1 (cg-RX-API-DMAC7.html)
AU (2) AU772222B2 (cg-RX-API-DMAC7.html)
BR (1) BR9916726A (cg-RX-API-DMAC7.html)
CA (1) CA2354194A1 (cg-RX-API-DMAC7.html)
CY (1) CY1107603T1 (cg-RX-API-DMAC7.html)
DE (1) DE69933581T2 (cg-RX-API-DMAC7.html)
DK (1) DK1140149T3 (cg-RX-API-DMAC7.html)
ES (1) ES2275359T3 (cg-RX-API-DMAC7.html)
IL (2) IL143994A0 (cg-RX-API-DMAC7.html)
PT (1) PT1140149E (cg-RX-API-DMAC7.html)
SI (1) SI1140149T1 (cg-RX-API-DMAC7.html)
WO (1) WO2000040260A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60140051D1 (de) * 2000-06-07 2009-11-12 Merck Serono Sa Coinsins Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
JP2004504834A (ja) 2000-08-01 2004-02-19 イスム リサーチ ディベロップメント カンパニー 胚性細胞の定方向分化
CN102302493B (zh) 2001-07-31 2015-08-12 健赞股份有限公司 活化祖细胞/干细胞的方法
WO2005032572A2 (en) 2003-10-03 2005-04-14 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
BRPI0519170A8 (pt) * 2004-12-22 2018-05-08 Ambrx Inc formulações de hormônio de crescimento humano que compreendem um aminoácido não naturalmente codificado
JP2013515081A (ja) * 2009-12-21 2013-05-02 アンブルックス,インコーポレイテッド 修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
EP0563485A1 (en) * 1992-03-30 1993-10-06 Schering-Plough In vitro generation of human dendritic cells and uses thereof
JPH08511263A (ja) * 1993-06-15 1996-11-26 ブリテッシュ バイオテック ファーマシューティカルズ リミテッド 造血細胞の放出と可動化
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
DE69433967D1 (de) * 1993-10-06 2004-09-30 Univ Florida Stammzellen-proliferations-faktor
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
CA2227241C (en) * 1995-07-21 2004-12-21 THE GOVERNMENT OF THE UNITED STATES, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
WO1997026326A1 (en) * 1996-01-16 1997-07-24 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
JP4042925B2 (ja) * 1996-11-20 2008-02-06 シスメックス株式会社 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
EP1016414B1 (en) * 1998-12-17 2004-09-08 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
DE60140051D1 (de) * 2000-06-07 2009-11-12 Merck Serono Sa Coinsins Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Also Published As

Publication number Publication date
EP1779865A1 (en) 2007-05-02
CY1107603T1 (el) 2013-03-13
IL143994A (en) 2009-06-15
DE69933581D1 (de) 2006-11-23
AU2103900A (en) 2000-07-24
EP1140149A1 (en) 2001-10-10
BR9916726A (pt) 2001-09-11
WO2000040260A1 (en) 2000-07-13
SI1140149T1 (sl) 2007-02-28
DK1140149T3 (da) 2007-02-19
JP4808316B2 (ja) 2011-11-02
AU772222B2 (en) 2004-04-22
US20060029581A1 (en) 2006-02-09
DE69933581T2 (de) 2007-06-21
AU2004203355B2 (en) 2007-05-17
CA2354194A1 (en) 2000-07-13
AU2004203355A1 (en) 2004-08-19
JP2002534393A (ja) 2002-10-15
PT1140149E (pt) 2007-01-31
IL143994A0 (en) 2002-04-21
ES2275359T3 (es) 2007-06-01
EP1016413A1 (en) 2000-07-05
EP1140149B1 (en) 2006-10-11

Similar Documents

Publication Publication Date Title
AU579595B2 (en) Enzyme-resistant immunomodulatory peptides
ES2112860T3 (es) Inmunoterapia adoptiva con interleukina-7.
ZA891818B (en) Composition inducing a binding
ATE198158T1 (de) Verfahren zur behandlung geschädigter und verminderter zellen
ATE348876T1 (de) Verfahren zur vermehrung von natürlichen killerzellen
ATE444078T1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
DE69634982D1 (de) Verfahren zur steigerung von hematopoietischen zellen
CY1107603T1 (el) Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης
GB9925964D0 (en) Hair transplantation
PT952772E (pt) Processos de utilizacao de fagocitos mononuclears para promover a regeneracao axonal
DE69231093D1 (de) Verwendung einer zellulären Zusammensetzung zur Behandlung von menschlichen oder tierischen Organismen
DK0646576T3 (da) Vitamin D3-analoger
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
ES8800139A2 (es) Mejoras introducidas en el objeto de la patente principal por un procedimiento para la preparacion de derivados de urea.
DE69433851D1 (de) Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv
Fanning In vitro sensitization of human lymphocytes to sheep erythrocytes
DE69916302D1 (de) Verwendung von dendritischen zellen-depletierten zusammensetzungen zur verbesserung der transplantation von allogenen hämatopoietischen zellen
IT1172584B (it) Metodo per la protezione biologica degli innesti delle piante, in specie del castagno, con microorganismi antagonisti
UA10130A (uk) Спосіб стимулювання проліферативної активності клітин кісткового мозку у летально опромінених тварин
UA36324A (uk) Спосіб стимуляції гемопоетичної активності кріоконсервованого аломієлотрансплантата
IT8619874A0 (it) Procedimento per la produzione su scala industriale di microrganismi autotrofi, in particolare alghe unicellulari quali spirulina maxima.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1140149

Country of ref document: EP

EEFA Change of the company name